Contact PD/PI: Murphy, Timothy F Buffalo Clinical and Translational Research Center The Buffalo Translational Consortium (BTC), which includes 12 major academic, research and healthcare institutions and 5 influential community partners in our region, have embarked on a comprehensive strategic plan to build a strong foundation for clinical and translational research in response to our community needs. Buffalo is the second most populous city in New York State and has a rich cultural history. The distribution of underrepresented minorities who experience health disparities in Buffalo in 2015 (50%) parallels that projected for the US in 2050, making Buffalo a microcosm of what the US will look like in 35 years. The vision for our CTSA hub is to develop, test and share novel approaches to improve health and reduce health disparities in our community, which represents a ?population of the future?. Improving health in our community and the nation will require innovative research across the full T1 through T4 translational spectrum. In 2012, the University at Buffalo opened the new 170,000 ft2 state-of-the-art Clinical and Translational Research Center (CTRC) devoted entirely to clinical and translational research. The CTRC provides a centralized facility, including translational research laboratories, a clinical research center, an imaging center, a lab animal facility and a biorepository. The CTRC and other enormous BTC investments to build a 21st century Academic Health Center creates a setting for a CTSA to provide the key piece to transform our capacity to bring discoveries in the laboratory, the clinic and the community to benefit individual and public health by sharing expertise and innovative approaches to translational science as part of the national consortium. We will bring strengths to the CTSA consortium, including developing novel health informatics tools, leveraging our strength as a leading center on research in standards and ontologies; new approaches to community-based research developed with our community; testing and disseminating ontology-based methods to share translational image data; and one of the few full service Drug Development Services in the consortium. With a CTSA we will 1) accelerate the development, implementation and dissemination of new healthcare interventions and their translation into the community through innovative research across the T1 through T4 spectrum, 2) train and develop an excellent and diverse workforce to ensure that translational researchers and their teams have the skills and knowledge to advance translation of discoveries, 3) build a translational science pipeline that integrates data from multiple sources and combines data analysis methods to discover diagnostic, therapeutic and preventive interventions, and 4) streamline clinical research processes with a focus on quality to enhance recruitment of special populations across the lifespan and groups with health disparities, and accelerate multi-site clinical trial initiation. Building on our unique strengths will enhance both our local and national CTSA network capacity through collaboration and sharing expertise and resources. Project Summary/Abstract Page 272 Contact PD/PI: Murphy, Timothy F Buffalo Clinical and Translational Research Center

Public Health Relevance

The Buffalo Clinical and Translational Research Center is the coordinating center of the Buffalo Translational Consortium which will perform innovative research across the T1 through T4 translational spectrum to improve health in our community and the nation. We have brought together the region's premier research, educational and clinical institutions with influential community partners to create a shared environment to bring discoveries in the laboratory, clinic and community to benefit individual and public health. Project Narrative Page 273

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR001412-03S1
Application #
9418163
Study Section
Special Emphasis Panel (ZTR1-SRC (99))
Program Officer
Rosemond, Erica
Project Start
2015-08-12
Project End
2019-03-31
Budget Start
2017-05-11
Budget End
2018-03-31
Support Year
3
Fiscal Year
2017
Total Cost
$486,567
Indirect Cost
$171,392
Name
State University of New York at Buffalo
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
038633251
City
Amherst
State
NY
Country
United States
Zip Code
14228
Ackerman, Sarah D; Luo, Rong; Poitelon, Yannick et al. (2018) GPR56/ADGRG1 regulates development and maintenance of peripheral myelin. J Exp Med 215:941-961
Zhang, Ming; An, Bo; Qu, Yang et al. (2018) Sensitive, High-Throughput, and Robust Trapping-Micro-LC-MS Strategy for the Quantification of Biomarkers and Antibody Biotherapeutics. Anal Chem 90:1870-1880
Guttuso Jr, T; Bergsland, N; Hagemeier, J et al. (2018) Substantia Nigra Free Water Increases Longitudinally in Parkinson Disease. AJNR Am J Neuroradiol :
Mosleh, Wassim; Sheikh, Ali; Said, Zaid et al. (2018) The use of cardiac-CT alone to exclude left atrial thrombus before atrial fibrillation ablation: Efficiency, safety, and cost analysis. Pacing Clin Electrophysiol :
Ferguson, Scott W; Wang, Jinli; Lee, Christine J et al. (2018) The microRNA regulatory landscape of MSC-derived exosomes: a systems view. Sci Rep 8:1419
Grape, Annette; Rhee, Hyekyun; Wicks, Mona et al. (2018) Recruitment and retention strategies for an urban adolescent study: Lessons learned from a multi-center study of community-based asthma self-management intervention for adolescents. J Adolesc 65:123-132
Schweser, Ferdinand; Raffaini Duarte Martins, Ana Luiza; Hagemeier, Jesper et al. (2018) Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality. Neuroimage 167:438-452
Perez, Antonia C; Johnson, Antoinette; Chen, Ziqiang et al. (2018) Mapping Protective Regions on a Three-Dimensional Model of the Moraxella catarrhalis Vaccine Antigen Oligopeptide Permease A. Infect Immun 86:
Hutson, Alan D (2018) A robust semi-parametric warping estimator of the survivor function with an application to two-group comparisons. Stat Methods Med Res 27:384-397
Fillo, Jennifer; Heavey, Sarah Cercone; Homish, D Lynn et al. (2018) Deployment-Related Military Sexual Trauma Predicts Heavy Drinking and Alcohol Problems Among Male Reserve and National Guard Soldiers. Alcohol Clin Exp Res 42:111-119

Showing the most recent 10 out of 238 publications